Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 116Terminated 19Unknown 8Recruiting 8Withdrawn 5Active not recruiting 5Suspended 1No longer available 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 7Lymphoid 3Myeloid 2Sarcoma 1Other 1Classical hematology 1

Conditions

Sarcoma 7Osteosarcoma 4Lymphoma 3Prostatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Gliosarcoma 2Glioblastoma 2Gastrointestinal Stromal Tumors 2Dendritic Cell Sarcoma, Interdigitating 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neuroblastoma 1Leukemia 1Histiocytic Sarcoma 1Glioma 1Gallbladder Neoplasms 1Eyelid Squamous Cell Carcinoma 1Endometrial Neoplasms 1

Interventions

RFB4(dsFv)-PE38 recombinant immunotoxin 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Leukemia × Sarcoma × Clear all
NCT00077493 2007-12-28

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

MedImmune LLC

Phase 1 Suspended
95 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡